MolecularMD Licenses NYU, MSKCC Patents to Develop PGx Test for BRAF Mutation

The licensing agreement pertains to a patent describing the diagnostic use of a fluorescent-based, allele-specific PCR assay to amplify the V600E mutation.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.